What is the therapeutic dose of enoxaparin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Therapeutic Dosing of Enoxaparin

The therapeutic dose of enoxaparin is 1 mg/kg subcutaneously every 12 hours for most patients, with specific adjustments required for certain populations including the elderly, those with renal impairment, and obese patients. 1, 2

Standard Therapeutic Dosing

  • Standard dose: 1 mg/kg subcutaneously every 12 hours 1, 2
  • Initial loading dose: In selected patients, an initial intravenous loading dose of 30 mg may be administered 1, 2
  • Duration: Continue for the duration of hospitalization or until PCI is performed 1

Population-Specific Dosing Adjustments

Age-Based Adjustments

  • Patients ≥75 years: 0.75 mg/kg subcutaneously every 12 hours (no initial IV bolus) 2

Renal Function Adjustments

  • Severe renal impairment (CrCl <30 mL/min): 1 mg/kg subcutaneously once daily 1, 2, 3
  • End-stage renal disease: Consider using unfractionated heparin instead due to its clearance by the reticuloendothelial system rather than renal elimination 1

Weight-Based Adjustments

  • Morbid obesity (BMI ≥40 kg/m²): Consider 0.8 mg/kg subcutaneously every 12 hours 2
  • Alternative for morbidly obese patients: Weight-based prophylactic dose of 0.5 mg/kg subcutaneously every 12 hours may achieve better anti-Xa levels 1

Clinical Context-Specific Dosing

Acute Coronary Syndrome

  • Standard approach: 1 mg/kg subcutaneously every 12 hours with an initial 30 mg IV bolus in selected patients 1, 2
  • PCI setting: If PCI is performed within 8 hours of last subcutaneous dose, no additional dose needed; if 8-12 hours have passed, add 0.3 mg/kg IV at time of PCI 1

Venous Thromboembolism

  • Standard treatment: 1 mg/kg subcutaneously every 12 hours 4
  • Alternative regimen: 1.5 mg/kg subcutaneously once daily has also shown equivalent efficacy 4

Important Clinical Considerations

  • Monitoring: Routine monitoring of anti-Xa levels is not required for most patients but may be considered in severe renal impairment, extreme body weights, or prolonged therapy 2
  • Neuraxial anesthesia timing: When neuraxial anesthesia is used, prophylactic doses of enoxaparin may be started 4 hours after catheter removal but not earlier than 12 hours after the block was performed 1
  • Concomitant medications: Avoid "stacking" with unfractionated heparin due to increased bleeding risk 1, 2

Bleeding Risk Management

  • For patients at high risk of bleeding but requiring anticoagulation, consider alternative agents such as fondaparinux or bivalirudin 1, 2
  • Major bleeding rates are significantly lower with the 1 mg/kg dose compared to higher doses (1.9% vs 6.5% with 1.25 mg/kg) 5

The therapeutic dosing of enoxaparin must be carefully selected based on patient characteristics, with particular attention to age, renal function, and weight to optimize efficacy while minimizing bleeding risk.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.